Select a section from the left sidebar
Amphimelibioside C
- Family: Animalia - Niphatidae
- Kingdom: Animalia
-
Class: Lipid
- Subclass: Ceramide Dihexoside
Canonical Smiles | CCCCCCCCCCCCCCCCCCCC[C@H](C(=O)N[C@H]([C@@H]([C@@H](C/C=C/CCCCCCCCCCC)O)O)CO[C@@H]1O[C@H](CO[C@H]2O[C@H](CO)[C@@H]([C@@H]([C@H]2O)O)O)[C@H]([C@@H]([C@H]1O)O)O)O |
---|---|
InChI | InChI=1S/C52H99NO15/c1-3-5-7-9-11-13-15-17-18-19-20-21-22-24-26-28-30-32-34-40(56)50(64)53-38(43(57)39(55)33-31-29-27-25-23-16-14-12-10-8-6-4-2)36-65-51-49(63)47(61)45(59)42(68-51)37-66-52-48(62)46(60)44(58)41(35-54)67-52/h29,31,38-49,51-52,54-63H,3-28,30,32-37H2,1-2H3,(H,53,64)/b31-29+/t38-,39+,40+,41+,42+,43-,44-,45+,46-,47-,48+,49+,51+,52-/m0/s1 |
InChIKey | KFCVBGVYKUTMSK-PYZNSCESSA-N |
Formula | C52H99NO15 |
HBA | 15 |
HBD | 11 |
MW | 978.36 |
Rotatable Bonds | 42 |
TPSA | 268.32 |
LogP | 5.49 |
Number Rings | 2 |
Number Aromatic Rings | 0 |
Heavy Atom Count | 68 |
Formal Charge | 0 |
Fraction CSP3 | 0.94 |
Exact Mass | 977.7 |
Number of Lipinski Rule Violations | 4 |
# | Species | Family | Kingdom | NCBI Taxonomy ID |
---|---|---|---|---|
1 | Amphimedon sp. | Niphatidae | Animalia | 178513 |
Showing of synonyms
Amphimelibioside C
No compound-protein relationship available.
SMILES: O1CCCCC1COC2CCCCO2
Level: 1
Mol. Weight: 978.36 g/mol
SMILES: C1CCOCC1
Level: 0
Mol. Weight: 978.36 g/mol
No bioactivities available.
Absorption
- Caco-2 (logPapp)
- -6.03
- Human Oral Bioavailability 20%
- Non-Bioavailable
- Human Intestinal Absorption
- Non-Absorbed
- Madin-Darby Canine Kidney
- 5640.33
- Human Oral Bioavailability 50%
- Non-Bioavailable
- P-Glycoprotein Inhibitor
- Inhibitor
- P-Glycoprotein Substrate
- Non-Substrate
- Skin Permeability
- 737956.97
Distribution
- Blood-Brain Barrier (CNS)
- -
- Blood-Brain Barrier
- Non-Penetrable
- Fraction Unbound (Human)
- 0.97
- Plasma Protein Binding
- 88.68
- Steady State Volume of Distribution
- -
Metabolism
- Breast Cancer Resistance Protein
- Non-Inhibitor
- CYP 1A2 Inhibitor
- Non-Inhibitor
- CYP 1A2 Substrate
- Non-Substrate
- CYP 2C19 Inhibitor
- Non-Inhibitor
- CYP 2C19 Substrate
- Non-Substrate
- CYP 2C9 Inhibitor
- Non-Inhibitor
- CYP 2C9 Substrate
- Non-Substrate
- CYP 2D6 Inhibitor
- Non-Inhibitor
- CYP 2D6 Substrate
- Non-Substrate
- CYP 3A4 Inhibitor
- Non-Inhibitor
- CYP 3A4 Substrate
- Non-Substrate
- OATP1B1
- Non-Inhibitor
- OATP1B3
- Inhibitor
Excretion
- Clearance
- -0.49
- Organic Cation Transporter 2
- Non-Inhibitor
- Half-Life of Drug
- -
Toxicity
- AMES Mutagenesis
- Safe
- Avian
- Toxic
- Bee
- Safe
- Bioconcentration Factor
- -17154.44
- Biodegradation
- Toxic
- Carcinogenesis
- Safe
- Crustacean
- Toxic
- Liver Injury I (DILI)
- Toxic
- Eye Corrosion
- Safe
- Eye Irritation
- Safe
- Maximum Tolerated Dose
- 0.48
- Liver Injury II
- Safe
- hERG Blockers
- Toxic
- Daphnia Maga
- 4.05
- Micronucleos
- Toxic
- NR-AhR
- Safe
- NR-AR
- Safe
- NR-AR-LBD
- Safe
- NR-Aromatase
- Safe
- NR-ER
- Safe
- NR-ER-LBD
- Safe
- NR-GR
- Safe
- NR-PPAR-gamma
- Safe
- NR-TR
- Safe
- T. Pyriformis
- -1339357645.27
- Rat (Acute)
- 2.71
- Rat (Chronic Oral)
- 5.15
- Fathead Minnow
- 1690662.32
- Respiratory Disease
- Safe
- Skin Sensitisation
- Safe
- SR-ARE
- Safe
- SR-ATAD5
- Safe
- SR-HSE
- Safe
- SR-MMP
- Safe
- SR-p53
- Safe
General Properties
- Boiling Point
- 150636573.01
- Hydration Free Energy
- -2.92
- Log(D) at pH=7.4
- -60.5
- Log(P)
- 11.17
- Log S
- -4.66
- Log(Vapor Pressure)
- -4960219.83
- Melting Point
- 61.91
- pKa Acid
- -36056.69
- pKa Basic
- -271.33
No predicted protein targets found for this compound.